Mitral valve homograft for mitral valve replacement in acute bacterial endocarditis

Homograft use for aortic valve replacement (AVR) in aortic valve acute bacterial endocarditis (ABE) has gained in popularity, due mainly to the relative resistance of homografts to infection. Recent success with mitral valve homograft use led us to apply homograft mitral valve replacement (MVR) in a...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of heart valve disease Vol. 8; no. 1; p. 71
Main Authors Reardon, M J, Vinnerkvist, A, LeMaire, S A
Format Journal Article
LanguageEnglish
Published England 01.01.1999
Subjects
Echocardiography, Transesophageal
Endocarditis, Bacterial - complications
Endocarditis, Bacterial - surgery
Female
Follow-Up Studies
Humans
Middle Aged
Mitral Valve - diagnostic imaging
Mitral Valve - surgery
Mitral Valve - transplantation
Mitral Valve Insufficiency - diagnostic imaging
Mitral Valve Insufficiency - etiology
Mitral Valve Insufficiency - surgery
Transplantation, Homologous - methods
Online AccessGet more information

Cover

More Information
Summary:Homograft use for aortic valve replacement (AVR) in aortic valve acute bacterial endocarditis (ABE) has gained in popularity, due mainly to the relative resistance of homografts to infection. Recent success with mitral valve homograft use led us to apply homograft mitral valve replacement (MVR) in a patient with severe ABE that was not amenable to valve repair. Following surgery, the patient improved rapidly with normalization of infection parameters and chest radiography, and was discharged home on postoperative day 11. Follow up echocardiography showed good function of the homograft mitral valve with no regurgitation. After four months, the patient had normal valve function, with no evidence of infection. In conclusion, MVR with a mitral valve homograft in the setting of ABE was satisfactory, though patient follow up was relatively short (four months).
ISSN:0966-8519